ROMATOİD ARTRİT VE KORTİKOSTEROİDLER

Year 2003, Volume: 4 Issue: 3, 33 - 39, 17.09.2003

Ö. Faruk Şendur Ali Aydeniz

Abstract

-

Keywords

Romatoid Artrit, Kortikosteroidler, Tedavi

Rheumatoid Arthritis and Corticosteroids

Abstract

Corticosteroids are hormons which are secreted from human adrenal cortex. They are used commonly intreatment of rheumatoid arthritis because of their antiinflamatory and immunmodulatory effect. There are reportsabout corticosteroids that they quickly and effectively suppress synovitis and prevent radiological progression aserosive changes. The side effects of corticosteroids should be known and prevention must be taken if it isnecessary

Keywords

RheumatoidArthritis, Corticosteroids, Treatment

References

• 1. Hench PS, Kendall EC, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex (17-hydroxy- 11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin 1949; 24:181-97.
• 2. Kersley GD, Glyn J. A concise international history of rheumatology and rehabilitation. Friends and foes. London: Royal Society of Medicine Services Ltd, 1991: 56-7 and 84-5.
• 3. Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis and intermittent hydarthrosis. Proc Staff Meet Mayo Clinic 1938; 13:157-72.
• 4. Kasch J, Hetenyi G Jr. An historical review of rheumatoid arthritis treatment: 1948 to 1952. Semin Arthritis Rheum 1997; 27:57-65.
• 5. Kirwan JR. Systemic corticosteroids. In: Klippel JH, Dieppe PA.(ed.s) Rheumatology. Harcourt Publishers Limited. 2000; 3.6.1-6.
• 6. Baxter HD, Forssham PH. Tissue effects of glucocorticoids.Am J Med. 1972; 53: 573-89.
• 7. Dimitrios TB, Ronald LW. Corticosteroids. In: Koopman JW.(ed) A textbook of rheumatology 14th Edition. Philadelphia: W.B. Saunders, 2001: 827-47.
• 8. Laan RFJM, Jansen TL, Th A, van Riel PLCM. Glucocorticosteroids in the management of rheumatoid arthritis. Br Soc Rheum 1999; 38: 6-12.
• 9. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immunemediated disease: Basic and clinical correlates. Ann Intern Med 1993;119:1198-208.
• 10. Chikanza IC, Petrou P, Kingsley G et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1281-8.
• 11. Eijsbouts A, van den Hoogen F, Laan R, Hermus A, de Waal Malefijt M, van de Putte L. Similar response of ACTH, cortisol and prolactin to surgery in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1998; 37:1138-9.
• 12. George E, Kirwan JR. Corticosteroid therapy in rheumatoid arthritis. Bailliere's Clin Rheumatol 1990; 4:621-47.
• 13. Bryon MA, Kirwan JR. Corticosteroids in rheumatoid arthritis: Is a trial of their disease modifying potential feasible?Ann Rheum Dis 1986;46:171-3.
• 14. West HF. Rheumatoid arthritis. The relevance of clinical knowledge to research activities. Abstr World Med 1967; 41:401-17.
• 15. Kirwan JR and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. The effect of glucocorticoids on joint destruction in rheumatoid arthritis New Engl J Med 1995; 333:142-6.
• 16. Saag KG, Criswell LA, Sems KM, Nettleman MD, Kolluri S. Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness.Arthritis Rheum 1996; 39:1818-25.
• 17. Gotzsche PC, Johansen HK. Meta-analysis of short term low dose prednisolone versus placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritis and osteoarthritis. Br Med J 1998;316:811-8.
• 18. Harris ED, Emkey RD, Nichols JE, Newberg A. Low dose prednisone therapy in rheumatoid arthritis: A double blind study. J Rheumatol 1983; 10:713-21.
• 19. Van Gestel AM, Laan RFJM, Haagsma CJ et al. Oral steriods as bridge therapy in RA patients starting with parenteral gold: A randomised double-blind placebocontrolled trial. Br J Rheumatol 1995; 34: 347-51.
• 20. Van Schaardenburg DJ, Valkema R, Dijkmans BAC, Papapoulos S, Zwinderman AH, Han H et al. Prednisone treatment of elderly-onset rheumatoid arthritis.Arthritis Rheum 1995; 38: 334-42.
• 21. Corkhill MM, Jirkham BW, Chikanza K, Gibson T, Panayi GS. Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: A 24 week randomised controlled trial. Br J Rheumatol 1990; 29:274-9.
• 22. Weusten BLAM, Jacobs JWG, Bijslma JWJ. Corticosteroid pulse therapy in active rheumatoid arthritis. SeminArthritis Rheum 1993; 23:183-92.
• 23. Liebling MR, Leib E, McLaughlin K, Blocka K, Furst DE, Nyman K et al. Pulse methylprednisolone in rheumatoid arthritis. A double-blind cross-over trial. Ann Intern Med 1981; 94:21-6.
• 24. Williams IA, Baylis EM, Shipley ME. A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. Lancet 1982;2:237-40.
• 25. Forster PJ, Grindulis KA, Neumann V et all. High-dose intravenous methylprednisolone in rheumatoid arthritis.Ann Rhem Dis 1982;41:444-6.
• 26. Neumann V, Hopkins R, Dixon J et al. Combination therapy with pulsed methyprednisolone in rheumatoid arthritis.Ann Rheum Dis 1985;44:747-51.
• 27. Bijlsma JW, Schenk Y, Ramselaar AC et al. Methylprednisolone pulse therapy in conjunction with azathioprine in rheumatoid arthritis. Clin Rheumatol 1986;5:499-504.
• 28. Axelrod L. Glucocorticoids. In: Kelley WN, Harris DE, Ruddy S, Sledge CB.(ed.s) Textbook of Rheumatology.4th Edition Philadelphia: W.B. Saunders, 1993: 779-796.
• 29. Boers M, Verhoeven AC, Markusse HM, Van de Laar M, Westhovens R, Van Denderen JC et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350:309-18.
• 30. Dixon R, Christy N. On the various forms of corticosteroid withdrawal syndrome. Am J Med 1980;68:224-30.
• 31. Reimer LG, Morris HG, Ellis EF. Growth of asthmatic children during treatment with alternate-day steroids. J Allergy Clin Immunol 1975;55:224-31.
• 32. Weisman MH. Corticosteroids in the treatment of rheumatologic diseases. Curr Opin Rheumatol 1995;7:183-90.
• 33. Grieco MH. The role of corticosteroid therapy in infection. Hosp Pract 1984;18:131-43.
• 34. Cooper C, Kirwan JR. The risk of local and systemic corticosteroid administration. Bailliére's Clin Rheumatol 1990;4:305-32.
• 35. Piper JM, Ray WA, Daughery JR, Griffen MR. Corticosteroid use and peptic ulcer-role of nonsteroidal anti-inflammatory drug. Ann Intern Med 1991; 114:735-40.
• 36. Laan RFJM, Van Reil PLCM, van de Putte LBA, Van Erning LJTO, van't Hof MA, Lemmens JAM. Low dose prednisolone induces rapid reversible axial bone loss in patients with rheumatoid arthritis:Arandomised controlled study.Ann Intern Med 1993;119:963-8.
• 37. Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S, Champion GD. Osteoporosis in rheumatoid arthritis: Safety of low dose corticosteroids. Ann Rheum Dis 1986;45:950-3.
• 38. Reid DM, Eastmond C, Rennie JAN. Hypothalamicpituitary-adrenal axis suppression after repeated intraarticular steroid injection.Ann Rheum Dis 1986;45:87.
• 39. Berger RG, Yount WJ. Immediate 'steroid flare' from intra-articular triamcinolone hexacetonide injection: Case report and review of the literature. Arthritis Rheum 1990;33:1284-6.